The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways

Nature Immunology

Volumn 8, Issue 11, 2007, Pages 1227-1235

  Zaru, Rossana ^a   Ronkina, Natalia ^b   Gaestel, Matthias ^b   Arthur, J Simon C ^a   Watts, Colin ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DORAMAPIMOD; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; P90 RIBOSOMAL S6 KINASE; PROTEIN TYROSINE KINASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL SPECIFICITY; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; MOUSE; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; DENDRITIC CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMMUNOBLOTTING; ISOENZYMES; MICE; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 35548930283     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1517     Document Type: Article

References (58)

1. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. & Amigorena, S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667 (2002).
2. Reis e Sousa, C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483 (2006).
3. Trombetta, E.S. & Mellman, I. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23, 975-1028 (2005).
4. MacAry, P.A. et al. Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells. Proc. Natl. Acad. Sci. USA 98, 3982-3987 (2001).
5. Chow, A., Toomre, D., Garrett, W. & Mellman, I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418, 988-994 (2002).
6. Kleijmeer, M. et al. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J. Cell Biol. 155, 53-63 (2001).
7. Shin, J.S. et al. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444, 115-118 (2006).
8. van Niel, G. et al. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25 885-894 (2006).
9. Blander, J.M. & Medzhitov, R. Regulation of phagosome maturation by signals from toll-like receptors. Science 304, 1014-1018 (2004).
10. West, M.A. et al. Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305, 1153-1157 (2004).
11. Lelouard, H. et al. Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 417, 177-182 (2002).
12. O'Neill, L.A. How Toll-like receptors signal: What we know and what we don't know. Curr. Opin. Immunol. 18, 3-9 (2006).
13. Hauge, C. & Frodin, M. RSK and MSK in MAP kinase signalling. J. Cell Sci. 119, 3021-3023 (2006).
14. Gaestel, M. MAPKAP kinases-MKs-two's company, three's a crowd. Nat. Rev. Mol. Cell Biol. 7, 120-130 (2006).
15. Roux, P.P. & Blenis, J. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344 (2004).
16. Deak, M., Clifton, A.D., Lucocq, L.M. & Alessi, D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17 4426-4441 (1998).
17. Waskiewicz, A.J., Flynn, A., Proud, C.G. & Cooper, J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909-1920 (1997).
18. Frodin, M., Jensen, C.J., Merienne, K. & Gammeltoft, S. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J. 19, 2924-2934 (2000).
19. Roux, P.P., Richards, S.A. & Blenis, J. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol. Cell Biol. 23, 4796-4804 (2003).
20. Dummler, B.A. et al. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J. Biol. Chem. 280, 13304-13314 (2005).
21. McCoy, C.E., Campbell, D.G., Deak, M., Bloomberg, G.B. & Arthur, J.S. MSK1 activity is controlled by multiple phosphorylation sites. Biochem. J. 387, 507-517 (2005).
22. Fisher, T.L. & Blenis, J. Evidence for two catalytically active kinase domains in pp90rsk. Mol. Cell. Biol. 16, 1212-1219 (1996).
23. Frodin, M. et al. A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J. 21, 5396-5407 (2002).
24. Rousseau, S. et al. Inhibition of SAPK2a/p38 prevents hnRNP AO phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J. 21, 6505-6514 (2002).
25. Neininger A. et al. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J. Biol. Chem. 277, 3065-3068 (2002).
26. Kotlyarov, A. et al. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat. Cell Biol. 1, 94-97 (1999).
27. Lavoie, J.N., Hickey, E., Weber, L.A. & Landry, J. Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J. Biol. Chem. 268, 24210-24214 (1993).
28. Soloaga, A. et al. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22, 2788-2797 (2003).
29. Thomson, S. et al. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 18, 4779-4793 (1999).
30. Ueda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S. & Fukunaga, R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol. Cell. Biol. 24, 6539-6549 (2004).
31. Kuma, Y. et al. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J. Biol. Chem. 280, 19472-19479 (2005).
32. Ronkina, N. et al. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol Cell. Biol. 27, 170-181 (2007).
33. Dalby, K.N., Morrice, N., Caudwell, F.B., Avruch, J. & Cohen, P. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273, 1496-1505 (1998).
34. Jensen, C.J. et al. 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. J. Biol. Chem. 274, 27168-27176 (1999).
35. Vanhaesebroeck, B. & Alessi, D.R. The P13K-PDK1 connection: More than just a road to PKB. Biochem. J. 346, 561-576 (2000).
36. Dufresne, S.D. et al. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol Cell Biol. 21, 81-87 (2001).
37. Cohen, M.S., Zhang, C., Shokat, K.M. & Taunton, J. Structural bioinformatics-based design of selective, irreversible kinase inhibitors. Science 308, 1318-1321 (2005).
38. Sapkota, G.P. et al. B1-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem. J. 401, 29-38 (2007).
39. Smith, J.A. et al. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res. 65, 1027-1034 (2005).
40. Vik, T.A. & Ryder, J.W. Identification of serine 380 as the major site of autophosphorylation of Xenopus pp90rsk. Biochem. Biophys. Res. Commun. 235, 398-402 (1997).
41. Hawkins, J., Zheng, S., Frantz, B. & LoGrasso, P. p38 map kinase substrate specificity differs greatly for protein and peptide substrates. Arch. Biochem. Biophys. 382, 310-313 (2000).
42. Kotlyarov, A. et al. Distinct cellular functions of MK2. Mol. Cell. Biol. 22, 4827-4835 (2002).
43. Manning, G., Whyte, D.B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912-1934 (2002).
44. Alessi, D.R. et al. Mechanism of activation of protein kinase B by insulin and 1GF-1. EMBO J. 15, 6541-6551 (1996).
45. Rane, M.J. et al. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J. Biol. Chem. 276, 3517-3523 (2001).
46. Wu, R. et al. Hsp27 regulates Akt activation and PMN apoptosis by scaffolding MK2 to Akt signal complex. J. Biol. Chem. 282, 21598-21608 (2007).
47. Cohen, M.S., Hadjivassiliou, H. & Taunton, J. A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. Nat. Chem. Biol. 3, 156-160 (2007).
48. Mathur, R.K., Awasthi, A., Wadhone, P., Ramanamurthy, B. & Saha, B. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med. 10, 540-544 (2004).
49. Douville, E. & Downward, J. EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2. Oncogene 15, 373-383 (1997).
50. Buxade, M. et al. The Mnks are novel components in the control of TNF-α biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23, 177-189 (2005).
51. + exchanger isoform-1. J. Biol. Chem. 274, 20206-20214 (1999).
52. West, M.A., Bretscher, M.S. & Watts, C. Distinct endocytatic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J. Cell Biol. 109, 2731-2739 (1989).
53. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
54. Woo, M.S., Ohta, Y., Rabinovitz, I., Stossel, T.P. & Blenis, J. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Mol. Cell. Biol. 24, 3025-3035 (2004).
55. Wiggin, G.R. et al. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell. Biol. 22, 2871-2881 (2002).
56. Cornish, G.H., Sinclair, L.V. & Cantrell, D.A. Differential regulafion of T-cell growth by IL-2 and IL-15. Blood 108, 600-608 (2006).
57. Alessi, D.R. et al. Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Methods Enzymol. 255, 279-290 (1995).
58. Davies, S.P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105 (2000).